Vaccines for Chlamydia trachomatis infections

The distinct trimeric structure of the immunodominant chlamydial antigen Major Outer Membrane Protein.

Nature communications·2026

Presentation of the protective epitope in a Chlamydia muridarum MOMP vaccine is dependent on γ-interferon-inducible lysosomal thiol reductase (GILT).

ImmunoHorizons·2026

Comparative evaluation of 5 combination adjuvants on immunogenicity and efficacy of approved seasonal influenza vaccines.

NPJ vaccines·2026

Chlamydia trachomatis Serovars from the C-Complex and the B- and C-Related Complexes Are Significantly More Pathogenic than Those from the B-Complex in C3H/HeN but Not in BALB/c Mice.

Pathogens (Basel, Switzerland)·2025

CT584 Is Not a Protective Vaccine Antigen against Respiratory Chlamydial Challenge in Mice.

Vaccines·2024

Structural Assessment of Chlamydia trachomatis Major Outer Membrane Protein (MOMP)-Derived Vaccine Antigens and Immunological Profiling in Mice with Different Genetic Backgrounds.

Vaccines·2024

Reporting disease control rates or clinical benefit rates in early clinical trials of anticancer agents: useful endpoint or hype?

Current opinion in investigational drugs (London, England : 2000)·2011

Abating progressive tissue injury and preserving function after CNS trauma: The role of inflammation modulatory therapies.

Current opinion in investigational drugs (London, England : 2000)·2010

Teriflunomide, an inhibitor of dihydroorotate dehydrogenase for the potential oral treatment of multiple sclerosis.

Current opinion in investigational drugs (London, England : 2000)·2010

Tralokinumab, an anti-IL-13 mAb for the potential treatment of asthma and COPD.

Current opinion in investigational drugs (London, England : 2000)·2010

Vedolizumab, a humanized mAb against the α4β7 integrin for the potential treatment of ulcerative colitis and Crohn's disease.

Current opinion in investigational drugs (London, England : 2000)·2010

Pitrakinra, a dual IL-4/IL-13 antagonist for the potential treatment of asthma and eczema.

Current opinion in investigational drugs (London, England : 2000)·2010

The Mediating Role of Patient Activation in the Association Between Illness Perception and Self-Management Behavior Among Patients with Oral Cancer.

Patient preference and adherence·2026

Carcinoid Heart Disease Presenting as Cardiogenic Shock: A Case Report.

Cureus·2026

Erratum: Preclinical study of using multiphoton microscopy to diagnose liver cancer and differentiate benign and malignant liver lesions (Erratum).

Journal of biomedical optics·2026

A cfDNA-based DNA methylation classifier for distinguishing prostate cancer from benign prostatic hyperplasia.

Prostate international·2026

Nanosystem-Mediated Intercellular Crosstalk Modulation in the Tumor Microenvironment for Enhanced Cancer Immunotherapy.

Drug design, development and therapy·2026

Complementary detection of clinically significant prostate cancer by magnetic resonance imaging fusion-targeted and systematic transrectal ultrasound-guided biopsy: influence of prostate-specific antigen and prostate-specific antigen density in a retrospective paired cohort.

Prostate international·2026

Related Experiment Videos

Vaccines for Chlamydia trachomatis infections

Related Concept Videos

The distinct trimeric structure of the immunodominant chlamydial antigen Major Outer Membrane Protein.

Presentation of the protective epitope in a Chlamydia muridarum MOMP vaccine is dependent on γ-interferon-inducible lysosomal thiol reductase (GILT).

Comparative evaluation of 5 combination adjuvants on immunogenicity and efficacy of approved seasonal influenza vaccines.

Chlamydia trachomatis Serovars from the C-Complex and the B- and C-Related Complexes Are Significantly More Pathogenic than Those from the B-Complex in C3H/HeN but Not in BALB/c Mice.

CT584 Is Not a Protective Vaccine Antigen against Respiratory Chlamydial Challenge in Mice.

Structural Assessment of Chlamydia trachomatis Major Outer Membrane Protein (MOMP)-Derived Vaccine Antigens and Immunological Profiling in Mice with Different Genetic Backgrounds.

Reporting disease control rates or clinical benefit rates in early clinical trials of anticancer agents: useful endpoint or hype?

Abating progressive tissue injury and preserving function after CNS trauma: The role of inflammation modulatory therapies.

Teriflunomide, an inhibitor of dihydroorotate dehydrogenase for the potential oral treatment of multiple sclerosis.

Tralokinumab, an anti-IL-13 mAb for the potential treatment of asthma and COPD.

Vedolizumab, a humanized mAb against the α4β7 integrin for the potential treatment of ulcerative colitis and Crohn's disease.

Pitrakinra, a dual IL-4/IL-13 antagonist for the potential treatment of asthma and eczema.

The Mediating Role of Patient Activation in the Association Between Illness Perception and Self-Management Behavior Among Patients with Oral Cancer.

Carcinoid Heart Disease Presenting as Cardiogenic Shock: A Case Report.

Erratum: Preclinical study of using multiphoton microscopy to diagnose liver cancer and differentiate benign and malignant liver lesions (Erratum).

A cfDNA-based DNA methylation classifier for distinguishing prostate cancer from benign prostatic hyperplasia.

Nanosystem-Mediated Intercellular Crosstalk Modulation in the Tumor Microenvironment for Enhanced Cancer Immunotherapy.

Complementary detection of clinically significant prostate cancer by magnetic resonance imaging fusion-targeted and systematic transrectal ultrasound-guided biopsy: influence of prostate-specific antigen and prostate-specific antigen density in a retrospective paired cohort.

Related Experiment Videos

Vaccines for Chlamydia trachomatis infections

Abstract:

Related Concept Videos

Related Articles